Core Insights - The 22nd World Traditional Chinese Medicine Conference was held in Sydney, Australia, focusing on the theme of "Cultural Dissemination and Technological Innovation of Traditional Chinese Medicine (TCM) from a Global Perspective" [1][3] Group 1: Conference Overview - The conference was organized by the World Federation of Chinese Medicine Societies and supported by various Australian organizations, including the Australian Conference Bureau and the Australian Tourism Bureau [3] - Key participants included TCM experts, government officials, and business representatives from around the world, engaging in discussions on the international development of TCM [1][3] Group 2: Company Initiatives - Guangzhou Pharmaceutical Group, a major partner of the conference, showcased its latest achievements in TCM internationalization, technological innovation, and cultural dissemination [3] - The company’s chairman, Li Xiaojun, emphasized the importance of modernizing TCM through digital transformation and establishing a comprehensive international presence [3][6] Group 3: Strategic Collaborations - During the conference, Guangzhou Pharmaceutical Group signed multiple strategic cooperation agreements with various international entities, focusing on cultural promotion, research collaboration, and market expansion [8] - Notably, the Wanglaoji Health Company plans to launch the WALOVI international can in Australia, enhancing its overseas market presence [8] Group 4: Expert Contributions - The conference featured expert lectures, including a report on the regulation of TCM by Diane Wilkinson from the Australian government, providing policy guidance for TCM internationalization [6] - Other presentations included discussions on continuous innovation in TCM products, highlighting the collaborative efforts in research and development [6]

Core Viewpoint - The ongoing trademark dispute between Jia Duo Bao and Wang Lao Ji has escalated, focusing on the overseas trademark ownership of "Wang Lao Ji" as both companies compete in international markets [2][10]. Group 1: Trademark Dispute - On September 30, Wang Lao Ji accused Jia Duo Bao of maliciously registering the "Wang Lao Ji" trademark overseas through offshore companies [3]. - Jia Duo Bao responded on October 10, asserting that it legally acquired the overseas trademark ownership in the 2000s and has registered it in over 60 countries [7][12]. - Both companies cite different legal rulings to support their claims, indicating a complex legal landscape surrounding the trademark ownership [13]. Group 2: Legal Background - The trademark conflict has been ongoing for years, with significant legal battles since their partnership ended in 2011, involving numerous lawsuits and substantial financial stakes [16]. - In 2018, a court ruled that Jia Duo Bao owed 1.44 billion yuan to Wang Lao Ji, but this was later overturned by the Supreme People's Court due to evidence issues [16]. - A recent ruling in July 2023 found Jia Duo Bao liable for infringement, ordering compensation of 317 million yuan, which Jia Duo Bao plans to appeal [16]. Group 3: Market Dynamics - The competition has now extended to international markets, with both companies vying for dominance in the growing global plant-based beverage sector, which is projected to grow at a compound annual growth rate of nearly 10% from 2019 to 2024 [19]. - Wang Lao Ji's international brand "WALOVI" was launched on August 18, 2025, and has seen a 6.5-fold increase in overseas market size over the past decade, with a compound annual growth rate exceeding 25% [20]. - Wang Lao Ji reported a revenue of 6.499 billion yuan in the first half of 2025, reflecting an 8.38% year-on-year increase, while net profit rose by 15.87% to 1.295 billion yuan [20].